Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma
- 1 January 2017
- journal article
- review article
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 56, 107-147
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 EY025253, R21 EY025074, P30 EY016665)
This publication has 136 references indexed in Scilit:
- Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium GuidanceDrug Safety, 2013
- Glaucomatous damage of the maculaProgress in Retinal and Eye Research, 2013
- Glaucoma Progression Analysis Software Compared with Expert Consensus Opinion in the Detection of Visual Field Progression in GlaucomaOphthalmology, 2012
- Incorporating life expectancy in glaucoma careEye, 2011
- Visual Field Progression in the Collaborative Initial Glaucoma Treatment StudyOphthalmology, 2009
- Practical recommendations for measuring rates of visual field change in glaucomaBritish Journal of Ophthalmology, 2008
- A framework for comparing structural and functional measures of glaucomatous damageProgress in Retinal and Eye Research, 2007
- Severity of Visual Field Loss and Health-related Quality of LifeAmerican Journal of Ophthalmology, 2007
- Validated Prediction Model for the Development of Primary Open-Angle Glaucoma in Individuals with Ocular HypertensionOphthalmology, 2007
- Management of Ocular Hypertension: A Cost-effectiveness Approach From the Ocular Hypertension Treatment StudyAmerican Journal of Ophthalmology, 2006